Sayad Pierre Sargis
Chief Medical Officer
Sayad Pierre Sargis has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 8 of those filings fall inside the rolling window. Most recent filing: Oct 13, 2026.
On the most recent filing, Sayad Pierre Sargis is listed as Chief Medical Officer at FENNEC PHARMACEUTICALS INC. Inside the rolling window, Sayad Pierre Sargis reported no open-market purchases and 1 open-market sale totaling $146K in FENC.
Companies traded
Other insiders at FENC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$146K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sayad Pierre Sargis made?
Sayad Pierre Sargis has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company since 2026.
Which companies does Sayad Pierre Sargis trade?
Sayad Pierre Sargis has filed SEC Form 4 disclosures for 1 company, including FENC.
When was Sayad Pierre Sargis's most recent SEC Form 4 filing?
Sayad Pierre Sargis's most recent SEC Form 4 filing on Tracefour is dated Oct 13, 2026.
What is Sayad Pierre Sargis's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sayad Pierre Sargis is listed as Chief Medical Officer.
What is Sayad Pierre Sargis's total buy and sell value in the current window?
Inside the rolling retention window, Sayad Pierre Sargis bought $0 and sold $146K based on SEC Form 4 filings.
What was Sayad Pierre Sargis's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,000 FENC shares on 2026-08-31, worth $146K, per SEC Form 4 filings.